[1]
Woon, D.T. et al. 2018. Disparity in public funding of therapies for metastatic castrate-resistant prostate cancer across Canadian provinces. Canadian Urological Association Journal. 12, 10 (Jul. 2018). DOI:https://doi.org/10.5489/cuaj.5378.